SCHEMBL19906061

SCHEMBL19906061

COc1ncccc1-c1cccc(-c2nc3cc(C)c(CC(=O)O)c(-c4ccc(Cl)cc4OC(C)(C)C)c3s2)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
CTSA P10619 6/20 0.36
EIF4E P06730 1/20 0.36
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
KLKB1 P03952 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
DHODH Q02127 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
GAA P10253 1/20 0.32
MDM2 Q00987 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19905797 0.89 EIF4E (0.39) KDM4ECTSAEIF4ELMNAMAPT
SCHEMBL19906322 0.87 CNR1 (0.38) KDM4ECTSALMNASMN1; SMN2MEN1
SCHEMBL19906060 0.87 KDM4E (0.38) KDM4ECTSAEIF4ELMNASMN1; SMN2
SCHEMBL19906086 0.85 KDM4E (0.39) KDM4ECTSALMNASMN1; SMN2MAPT
SCHEMBL19906314 0.84 KDM4E (0.40) KDM4ECTSALMNASMN1; SMN2MEN1
SCHEMBL19906157 0.83 KDM4E (0.38) KDM4ECTSALMNASMN1; SMN2MEN1
SCHEMBL19906323 0.82 SMN1; SMN2 (0.43) KDM4ECTSALMNASMN1; SMN2MEN1
SCHEMBL19906366 0.82 CTSA (0.34) KDM4ECTSALMNASMN1; SMN2MAPT
SCHEMBL19906137 0.82 PTGDR2 (0.39) KDM4ECTSAEIF4ELMNASMN1; SMN2
SCHEMBL19906044 0.82 SHMT1 (0.38) KDM4ECTSALMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070081-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2018-02-28 EP disclosed